Cytori Therapeutics, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cytori Therapeutics, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: SnowShredder	8/6/2010 9:04:43 PM
	of 251

Cytori's stem-cell device gets European approval for new uses Best of Luck, SS reuters.com >>>>>>>> Cytori's stem-cell device gets European approval for new uses Tue Jul 27, 2010 9:13am EDT * Gets approval for breast reconstruction * Also approved for soft-tissue repair, healing wounds * Shares up 6 pct pre-market July 27 (Reuters) - Cytori Therapeutics (CYTX.O) said it received European approval for the use of its stem-cell device in breast reconstruction, repair of soft tissue and in healing certain types of wounds, sending its shares up 6 percent. The company's Celution system extracts and separates stem and regenerative cells from a patient's own fat tissue to form a fat graft, which is used to reconstruct the affected breast or other soft tissue defects. "This broadens Cytori's ability to offer the Celution system to patients and hospitals and further supports the company's efforts to gain treatment reimbursement," the company said in a statement. Shares of the company were up 26 cents at $4.93 in pre-market trade. They closed at $4.67 Monday on Nasdaq. (Reporting by Anand Basu in Bangalore; Editing by Vinu Pilakkott)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next